Associated Papers
Development of iPSC-based clinical trial selection platform for patients with ultrarare diseases.
Sequiera GL et al.
Science Advances, 2022
Generation and Evaluation of Isogenic iPSC as a Source of Cell Replacement Therapies in Patients with Kearns Sayre Syndrome.
Lester Sequiera G et al.
Cells, 2021
Select a paper to view details